Glial fibrillary acidic protein (GFAP) is the main astroglial marker during astrogliogenesis, but it is also expressed in other cell types, including neural stem cells and old neurons. Activation of the JAK/STAT pathway by the IL-6 family of cytokines is the canonical pathway regulating GFAP expression, whereas retinoic acid is thought to be the only inducer of GFAP to operate independently of this pathway. Here, we show that retinoic acid receptor ␣ not only links retinoic acid signaling to the canonical cytokine-stimulated pathway leading to GFAP expression but that it also plays a key role in the synergistic actions of retinoic acid and cytokines on this pathway. Cytokines both potentiate retinoic acid receptor ␣ expression and enhance its binding to DNA and to the Stat3-p300/CBP-Smad transcriptional complex, the cornerstone of the canonical pathway. PI3K is upstream to all the key events leading to the expression of GFAP. Our results give new insights about the role of retinoic acid signaling in GFAP expression.The intermediate filament protein glial fibrillary acidic protein (GFAP) 2 is considered a cell type-specific marker for astrocytes. However, GFAP is expressed in some nerve cell populations, including hippocampal neurons of older individuals (1). It is also expressed in some precursor populations of nerve cells as well as in cells that can give rise to both nerve and glia (2-4). Finally, the expression levels of GFAP within individual cells is extremely variable, and higher expression levels may limit the tumorigenicity of subpopulations of cells within glioblastomas (5, 6). Because of the wide range of cellular phenotypes associated with GFAP, it is important to understand the molecular mechanisms that regulate its expression.The GFAP is regulated in part by the secretion of factors into the extracellular space (7). The canonical pathway for GFAP expression in astrocytes is triggered by the binding of cytokines from the interleukin-6 (IL-6) family to their receptors. These receptors subsequently activate the JAK/STAT intracellular pathway, leading to the expression of GFAP in astrocytes (7-9). Most of the other pathways known to participate in GFAP expression are connected at some point to this canonical pathway (10, 11). For example, some members of the tumor growth factor- (TGF-) superfamily of cytokines have little or no effect on GFAP synthesis by themselves, but they strongly potentiate GFAP induced by the IL-6 family of cytokines. They do so by triggering the phosphorylation, activation, and heterodimerization of Smad proteins, which then form a more potent transcriptional complex with p300/CBP and Stat3. As a consequence, the expression of GFAP is greatly enhanced (9, 12-14).All-trans-retinoic acid (RA), generally considered to be a neurogenic agent, is in fact a potent inducer of GFAP (14 -18). Studies with pharmacological agonists for the different retinoic acid receptors indicate that retinoic acid-induced GFAP expression is mediated by the activation of retinoic acid receptor (RAR) ␣ ...